← brief for 2026-11-12 · Slowing decline
Population Impact of the 2026 American College of Cardiology/American Heart Association Dyslipidemia Guideline on Lipid-Lowering Therapy Eligibility Among US Adults.
Key takeaways
This study analyzed health data from US adults to see how new cholesterol guidelines change who gets treatment. It found that more people with kidney disease would now qualify for cholesterol-lowering drugs. This shows a link between guidelines and treatment access, not a direct health outcome.
Who did this work
Hyun S · Sze CH · Singh S · Daneii P · Williams JL · Fernandez J
Source
Article · PubMed, CKD progression and prevention · 2026 Nov 12
https://pubmed.ncbi.nlm.nih.gov/43018043/